Truist Securities Reiterates Buy on Eli Lilly, Raises Price Target to $1612
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsReiterationPrice TargetHot
Truist Securities analyst Srikripa Devarakonda reiterates Eli Lilly (NYSE:LLY) with a Buy and raises the price target from $1376 to $1612.
Truist Securities analyst Srikripa Devarakonda reiterates Eli Lilly (NYSE:LLY) with a Buy and raises the price target from $1376 to $1612.